ArticleJournal of oncology2022

Clinical Efficacy of Pyrotinib Combined with Capecitabine in the Second-Line or Above Treatment for HER-2 Positive Advanced Breast Cancer and Its Association with Cell-Free DNA.

Yajun Miao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.